Introduction: Opioid Controversies: The Crisis

Abstract

Get full access to this article

View all access options for this article.

References

Marshall

, “Uncle Sam Is the Worst Drug Fiend in the World,” New York Times, March 12, 1911, available at <https://times-machine.nytimes.com/timesmachine/1911/03/12/104858335.pdf?pdf_redirect=true&ip=0> (last visited May 22 2020).

E.F.

McCance-Katz

, “National Survey on Drug Use and Health: 2018,” US Department of Health and Human Services, (2019), available at <https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/Assistant-Secretary-nsduh2018_presentation.pdf> (last visited May 22, 2020).

Opioid overdose crisis, National Institute on Drug Abuse: Advancing Addiction Science, February 2020, available at <https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis#> (last visited May 22, 2020).

C.S.

Florence ,

Zhou ,

Luo , and

Xu , “The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013” Medical Care 54, no. 10 (2016): 901-906.

The Writing Group for the SUPPORT Investigators, “A Controlled Trial to Improve Care for Seriously III Hospitalized Patients: The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT),” Journal of the American Medical Association 274, no. 20 (1995): 1591-1598.

Campbell

, “Pain as the 5th Vital Sign,” American Pain Society, Pain Forum 5 (1996): 85–88.

B.A.

Chidgey ,

K.L.

McGinigle , and

P.P.

McNaull , “When a Vital Sign Leads a Country Astray — The Opioid Epidemic,” Journal of the American Medical Association 154, no. 11 (2019): 987-988.

Christo

, “Opioids May Be Appropriate for Chronic Pain,” Journal of Law, Medicine & Ethics 48, no. 2 (2020): 241-248.

B.C.

Fink ,

Uyttebrouck , and

R.S.

Larson , “An Effective Intervention: Limiting Opioid Prescribing as a Means of Reducing Opioid Analgesic Misuse, and Overdose Deaths,” Journal of Law, Medicine & Ethics 48, no. 2 (2020): 249-258.

10.

S.G

Kertesz ,

A.J.

Gordon , and

Manhapra , “Nonconsensual Dose Reduction Mandates Are Not Justified Clinically or Ethically: An Analysis,” Journal of Law, Medicine & Ethics 48, no. 2 (2020): 259-267.

11.

A.R.

Williams

, “Cannabis as a Gateway Drug for Opioid Use Disorder,” Journal of Law, Medicine & Ethics 48, no. 2 (2020): 268-274.

12.

J.F.

Arnold and

R.M.

Sade , “Regulating Marijuana Use in the United States: Moving Past the Gateway Hypothesis of Drug Use,” Journal of Law, Medicine & Ethics 48, no. 2 (2020): 275-278.

13.

R.L.

Haffajee

, “The Public Health Value of Opioid Litigation,” Journal of Law, Medicine & Ethics 48, no. 2 (2020): 279-292.

14.

R.C.

Ausness

, “Is Litigation the Way to Combat the Opioid Crisis?” Journal of Law, Medicine & Ethics 48, no. 2 (2020): 293-306.

Introduction: Opioid Controversies: The Crisis — Causes and Solutions

Abstract

Get full access to this article

References